| 发明名称 |
CDR-MODIFIED ANTI-SIGLEC-15 ANTIBODY |
| 摘要 |
To provide an abnormal-bone-metabolism treatment and/or a prophylactic pharmaceutical composition targeting a protein coded for by a gene that is strongly expressed in osteoclasts. The provision, etc., of a pharmaceutical composition containing an antibody that specifically recognizes human SIGLEC15 and exhibits the effect of inhibiting the formation of osteoclasts. |
| 申请公布号 |
CA2868959(A1) |
申请公布日期 |
2013.10.03 |
| 申请号 |
CA20132868959 |
申请日期 |
2013.03.29 |
| 申请人 |
DAIICHI SANKYO COMPANY, LIMITED |
发明人 |
HIRUMA, YOSHIHARU;KIMURA, TAKAKO;SHIMIZU, HIRONARI |
| 分类号 |
C12N15/09;A61K39/395;A61P1/02;A61P7/00;A61P19/00;A61P19/02;A61P19/10;A61P29/00;A61P35/00;A61P43/00;C07K16/18;C07K16/46;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/08 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
